在小儿甲状腺癌患者的肺转移中FAPI活性升高,甲状腺蛋白升高和阴性光学
Taipeng Du1, Peiying Lin2, Chenghang Liu1
1Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu.
Clinical nuclear medicine
|February 6, 2026
概括
纤维细胞激活蛋白抑制剂 (FAPI) PET/CT扫描显示,在患有TENIS综合征的儿童中检测复发性甲状腺癌具有前途. 由于儿科患者可能出现假阳性结果,建议谨慎使用.
科学领域:
- 在瘤学瘤学.
- 核医学是一种核医学.
- 儿科成像学 儿科成像学
背景情况:
- 甲状腺癌在患有甲状腺蛋白升高和阴性光学 (TENIS) 综合征的患者中复发的发现具有挑战性.
- 纤维细胞激活蛋白抑制剂 (FAPI) PET/CT是一种新兴的成像方式,用于检测成人复发性和转移性甲状腺癌.
研究的目的:
- 评估18F-FAPI PET/CT在患有TENIS综合征的儿科患者中的实用性.
- 评估FAPI PET/CT在儿科瘤学中的准确性和潜在限制.
主要方法:
- 一名被诊断患有TENIS综合征的7岁男孩接受了18F-FAPI PET/CT扫描.
- 扫描分析了已知和可疑转移部位的标记物吸收.
主要成果:
- 18F-FAPI PET/CT扫描显示了右的转移性淋巴结和肺转移中的强烈的痕迹活性.
- 在右侧的骨骨同症区域也观察到强烈的吸收,引发了对错误阳性结果的担忧.
结论:
- 这一案例凸显了FAPI PET/CT在TENIS综合征的儿科患者中诊断复发性甲状腺癌的潜力.
- 这些发现强调了仔细解释和意识到儿科成像中潜在的假阳性结果的重要性.
相关概念视频
Freezing Point Depression and Boiling Point Elevation
40.3K
Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
40.3K
Elevation of Intermediate Points on Vertical Curves
308
Vertical curves are essential in roadway design because they provide smooth transitions between varying roadway grades. Designing vertical curves involves calculating intermediate elevations and identifying the curve's highest or lowest point, which is essential for optimal roadway performance.Intermediate elevations on a vertical curve are determined using the tangent offset method. This method considers the initial elevation at the start of the curve, the grades, and the curve's geometry. The...
308
Pharmacokinetics in Pediatric Patients: Drug Excretion
266
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266
Pharmacokinetics in Pediatric Patients: Drug Distribution
317
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
317
Pharmacokinetics in Pediatric Patients: Drug Metabolism
237
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
237
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
305
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
305


